Published in Biochim Biophys Acta on March 07, 2000
Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect Immun (2001) 1.38
Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci U S A (2004) 1.32
Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect Immun (2004) 1.31
Genomic comparison of Escherichia coli K1 strains isolated from the cerebrospinal fluid of patients with meningitis. Infect Immun (2006) 1.12
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs (2010) 1.12
Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am J Pathol (2006) 1.07
Microbial metalloproteinases mediate sensing of invading pathogens and activate innate immune responses in the lepidopteran model host Galleria mellonella. Infect Immun (2006) 1.06
The cell envelope subtilisin-like proteinase is a virulence determinant for Streptococcus suis. BMC Microbiol (2010) 1.02
Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin. Antimicrob Agents Chemother (2005) 0.99
Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin. J Biol Chem (2010) 0.97
Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother (2011) 0.96
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother (2006) 0.94
Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage. Biol Chem (2009) 0.92
Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect Immun (2001) 0.92
Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. FASEB J (2011) 0.91
Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases. J Oral Microbiol (2014) 0.91
Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase. Chem Commun (Camb) (2013) 0.88
Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy. Antimicrob Agents Chemother (2012) 0.87
3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB. ACS Med Chem Lett (2012) 0.85
Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity. Cell Death Dis (2013) 0.84
Antiproteases as therapeutics to target inflammation in cystic fibrosis. Open Respir Med J (2010) 0.84
Specific protease activity indicates the degree of Pseudomonas aeruginosa infection in chronic infected wounds. Eur J Clin Microbiol Infect Dis (2012) 0.82
Non-conventional therapeutics for oral infections. Virulence (2015) 0.81
Effect of protease inhibitors on the quantitative and qualitative assessment of oral microorganisms. FEMS Microbiol Lett (2010) 0.81
SufA - a bacterial enzyme that cleaves fibrinogen and blocks fibrin network formation. Microbiology (2009) 0.80
Syntheses and biological evaluation of 2-amino-3-acyl-tetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activity. Org Biomol Chem (2014) 0.78
Benzamidine derivatives inhibit the virulence of Porphyromonas gingivalis. Mol Oral Microbiol (2012) 0.78
A zymography analysis of proteinase activity present in Leptospira. Curr Microbiol (2010) 0.77
Presence of 46 kDa gelatinase on the outer membrane of Leptospira. Curr Microbiol (2011) 0.77
Silver-zeolite combined to polyphenol-rich extracts of Ascophyllum nodosum: potential active role in prevention of periodontal diseases. PLoS One (2014) 0.76
The Role of Proteinase-Activated Receptors 1 and 2 in the Regulation of Periodontal Tissue Metabolism and Disease. J Immunol Res (2017) 0.75
Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun (1999) 1.96
Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res (1999) 1.90
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood (2001) 1.77
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol (1996) 1.69
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res (1997) 1.56
Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J Biol Chem (2001) 1.56
Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem (1998) 1.43
Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem (1997) 1.43
Are bacterial proteinases pathogenic factors? Trends Microbiol (1995) 1.39
Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis (1999) 1.39
Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun (2001) 1.35
Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett (1998) 1.33
Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol (2008) 1.17
Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect Immun (1995) 1.17
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J (1996) 1.17
Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett (1998) 1.16
Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun (1996) 1.15
Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (gingipains) of Porphyromonas gingivalis. J Bacteriol (2001) 1.14
A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun (1998) 1.14
Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun (1999) 1.13
Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect Immun (1995) 1.13
Genetic variation of Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with arginine or lysine specificity. Biol Chem (1998) 1.10
Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem (1997) 1.09
Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem (1999) 1.09
Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol (2008) 1.08
Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus. Infect Immun (2000) 1.08
Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem (1997) 1.07
A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages. Cell Death Differ (2006) 1.05
[Optimal time for treating cryptorchism (author's transl)]. Dtsch Med Wochenschr (1975) 1.04
pH-regulated secretion of a glyceraldehyde-3-phosphate dehydrogenase from Streptococcus gordonii FSS2: purification, characterization, and cloning of the gene encoding this enzyme. J Dent Res (2001) 1.04
Amino-acid sequence and three-dimensional structure of the Staphylococcus aureus metalloproteinase at 1.72 A resolution. Structure (1998) 1.04
Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution. J Mol Biol (1992) 1.04
The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem (1986) 1.04
Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol Lett (1992) 1.03
Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis. Evidence for a role in the inactivation of human alpha1-proteinase inhibitor. J Biol Chem (1999) 1.02
Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem (1997) 1.00
Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun (2000) 0.97
Proteolysis of ICAM-1 on human oral epithelial cells by gingipains. J Dent Res (2003) 0.97
Porphyromonas gingivalis DPP-7 represents a novel type of dipeptidylpeptidase. J Biol Chem (2000) 0.96
Serpins: structure and mechanism of action. Biol Chem Hoppe Seyler (1990) 0.95
The potential role of alpha 2-macroglobulin in the control of cysteine proteinases (gingipains) from Porphyromonas gingivalis. J Periodontal Res (1997) 0.95
Unaltered expression of the major protease genes in a non-virulent recA-defective mutant of Porphyromonas gingivalis W83. Oral Microbiol Immunol (2000) 0.95
The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins. J Biol Chem (1989) 0.95
Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells. J Clin Invest (1995) 0.94
The role of proteolytic enzymes in the development of pulmonary emphysema and periodontal disease. Am J Respir Crit Care Med (1994) 0.93
Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology (1996) 0.92
Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother (2001) 0.92
Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease. Infect Immun (2001) 0.92
Stimulation of proteinase and amidase activities in Porphyromonas (Bacteroides) gingivalis by amino acids and dipeptides. Infect Immun (1991) 0.91
Evidence of mutualism between two periodontal pathogens: co-operative haem acquisition by the HmuY haemophore of Porphyromonas gingivalis and the cysteine protease interpain A (InpA) of Prevotella intermedia. Mol Oral Microbiol (2013) 0.91
Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J Periodontal Res (2009) 0.91
A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J Biol Chem (1998) 0.90
Activation of human prothrombin by arginine-specific cysteine proteinases (Gingipains R) from porphyromonas gingivalis. J Biol Chem (2001) 0.89
Purification and characterization of a novel endopeptidase in ragweed (Ambrosia artemisiifolia) pollen. J Biol Chem (1996) 0.89
Transposition of the endogenous insertion sequence element IS1126 modulates gingipain expression in Porphyromonas gingivalis. Infect Immun (1999) 0.89
The HA2 haemagglutinin domain of the lysine-specific gingipain (Kgp) of Porphyromonas gingivalis promotes micro-oxo bishaem formation from monomeric iron(III) protoporphyrin IX. Microbiology (2006) 0.89
Regulation of alpha 1-antichymotrypsin synthesis in cells of epithelial origin. FEBS Lett (1995) 0.88
Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues. Arzneimittelforschung (1988) 0.88
Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II). Oral Microbiol Immunol (2006) 0.86
Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid. Mol Oral Microbiol (2011) 0.86
In vitro testing the potential of a novel chimeric IgG variant for inhibiting collagen fibrils formation in recurrent hereditary gingival fibromatosis: chimeric antibody in a gingival model. J Physiol Pharmacol (2014) 0.85
Effect of calcium binding on conformational changes of staphylococcal metalloproteinase measured by means of intrinsic protein fluorescence. Biochim Biophys Acta (1986) 0.84
The functional role of acute phase plasma proteinase inhibitors. Tokai J Exp Clin Med (1988) 0.84
Gingipain enzymes from Porphyromonas gingivalis preferentially bind immobilized extracellular proteins: a mechanism favouring colonization? J Periodontal Res (2008) 0.83
Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo. Infect Immun (2001) 0.83
Effect of metalloproteinase from Staphylococcus aureus on in vitro stimulation of human lymphocytes. Immunol Lett (1991) 0.83
Purification and characterization of an arginine-specific peptidase from ragweed (Ambrosia artemisiifolia) pollen. Am J Respir Cell Mol Biol (1998) 0.82
Inhibition of distant caspase homologues by natural caspase inhibitors. Biochem J (2001) 0.82
A relationship between proteinase activity and clinical parameters in the treatment of periodontal disease. J Clin Periodontol (1998) 0.82
Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis. Biochem J (2001) 0.82
Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis. J Periodontal Res (2012) 0.82
Activation of protein C by arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis. Biol Chem (1999) 0.82
Cartilage proteoglycan degradation by a mouse transformed macrophage cell line is mediated by macrophage metalloelastase. Inflamm Res (1999) 0.81
Inactivation of alpha1-proteinase inhibitor as a broad screen for detecting proteolytic activities in unknown samples. Anal Biochem (1998) 0.81
Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases. Biol Chem (1999) 0.81
Differential regulation by Toll-like receptor agonists reveals that MCPIP1 is the potent regulator of innate immunity in bacterial and viral infections. J Innate Immun (2012) 0.81
Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor. Adv Exp Med Biol (1996) 0.81
Comparison of pathogenic properties between two types of arginine-specific cysteine proteinases (gingipains-R) from Porphyromonas gingivalis. Microb Pathog (2000) 0.81
Comparison of antiproteolytic activities of alpha-1-proteinase inhibitors from the plasma of some mammalian species. Comp Biochem Physiol B (1986) 0.81
Equine leukocyte elastase inhibitor. Primary structure and identification as a thymosin-binding protein. J Biol Chem (1992) 0.81
Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy. Protein Sci (1996) 0.81
The role of bacterial and host proteinases in periodontal disease. Adv Exp Med Biol (2000) 0.80
Elastinolytic activity of horse leukocyte proteinases. Comparison with elastases from human leukocytes and porcine pancreas. Folia Histochem Cytobiol (1986) 0.80
Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis. Mol Pathol (1997) 0.80
[Infusion therapy during transurethral prostatectomy]. Infusionsther Klin Ernahr (1980) 0.79
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal. J Thromb Haemost (2007) 0.79
Detection of Porphyromonas gingivalis in gingival exudate by a dipeptide-enhanced trypsin-like activity. J Periodontol (1994) 0.79
Chemoattractant activity of Staphylococcus aureus serine proteinase modified human plasma alpha-1-proteinase inhibitor. Antonie Van Leeuwenhoek (1989) 0.79
Comparative properties of human alpha-1-proteinase inhibitor glycosylation variants. FEBS Lett (1990) 0.79
The gingipains from Porphyromonas gingivalis do not directly induce osteoclast differentiation in primary mouse bone marrow cultures. J Periodontal Res (2008) 0.79
Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway. Mol Oral Microbiol (2014) 0.78
Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells. J Immunol (1997) 0.78
Benzamidine derivatives inhibit the virulence of Porphyromonas gingivalis. Mol Oral Microbiol (2012) 0.78
Origin of circulating acute phase cytokines: modified proteins may trigger IL-6 production by macrophages. Preliminary report. J Physiol Pharmacol (1994) 0.78